Published in Bioorg Med Chem on November 02, 2006
Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb. J Drug Deliv (2012) 0.98
Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine. Nanomedicine (Lond) (2014) 0.94
Synthesis and characterization of polyethylenimine-based iron oxide composites as novel contrast agents for MRI. MAGMA (2008) 0.91
Controlling subcellular delivery to optimize therapeutic effect. Ther Deliv (2010) 0.84
Smart polymeric nanoparticles for cancer gene delivery. Mol Pharm (2015) 0.82
Lipid-Based Nanocarriers for RNA Delivery. Curr Pharm Des (2015) 0.81
Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery. J Histochem Cytochem (2013) 0.79
Regulation of angiogenesis through the efficient delivery of microRNAs into endothelial cells using polyamine-coated carbon nanotubes. Nanomedicine (2016) 0.76
High gene delivery efficiency of alkylated low-molecular-weight polyethylenimine through gemini surfactant-like effect. Int J Nanomedicine (2014) 0.76
MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol Cell (2007) 2.10
FIOH-sponsored newsletter misrepresents asbestos hazards in Zimbabwe. Int J Occup Environ Health (2006) 2.02
Estrogen receptor-alpha and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase. Circ Res (2008) 1.75
Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 cases. Blood (2009) 1.74
The interaction between a sexually transferred steroid hormone and a female protein regulates oogenesis in the malaria mosquito Anopheles gambiae. PLoS Biol (2013) 1.70
Polysaccharide hydrogels for modified release formulations. J Control Release (2007) 1.60
Rightward and leftward bisection biases in spatial neglect: two sides of the same coin? Brain (2007) 1.48
Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Mov Disord (2009) 1.43
Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone. Haematologica (2002) 1.39
Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation. Pain (2011) 1.35
Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer. Mol Cancer Res (2006) 1.33
Supramolecular association in proton-transfer adducts containing benzamidinium cations. II. Concomitant polymorphs of the molecular salt of 2,6-dimethoxybenzoic acid with benzamidine. Acta Crystallogr C (2012) 1.29
Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome. Mov Disord (2007) 1.28
MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. EMBO J (2009) 1.23
Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord (2005) 1.20
Signaling through estrogen receptors modulates telomerase activity in human prostate cancer. J Clin Invest (2002) 1.14
MDM4 (MDMX) overexpression enhances stabilization of stress-induced p53 and promotes apoptosis. J Biol Chem (2003) 1.10
Polyethylenimine in medicinal chemistry. Curr Med Chem (2008) 1.09
Impulsivity and compulsivity in drug-naïve patients with Parkinson's disease. Mov Disord (2011) 1.08
Erythropoietin in heart and vessels: focus on transcription and signalling pathways. J Thromb Thrombolysis (2008) 1.07
Mutations in B9D1 and MKS1 cause mild Joubert syndrome: expanding the genetic overlap with the lethal ciliopathy Meckel syndrome. Orphanet J Rare Dis (2014) 1.07
Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood (2003) 1.06
Dandy-Walker malformation and Wisconsin syndrome: novel cases add further insight into the genotype-phenotype correlations of 3q23q25 deletions. Orphanet J Rare Dis (2013) 1.06
MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts. Oncogene (2002) 1.04
A novel near-infrared indocyanine dye-polyethylenimine conjugate allows DNA delivery imaging in vivo. Bioconjug Chem (2008) 1.04
Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization. Cancer Res (2005) 1.03
REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease. Mov Disord (2006) 1.03
Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation. J Med Chem (2008) 1.03
Focal muscle vibration in the treatment of upper limb spasticity: a pilot randomized controlled trial in patients with chronic stroke. Arch Phys Med Rehabil (2012) 1.02
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds. J Med Chem (2009) 1.01
Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia. J Biol Chem (2005) 1.01
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. Haematologica (2013) 1.01
White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia. Haematologica (2010) 0.98
Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia. Mov Disord (2006) 0.97
Natural and synthetic G-quadruplex interactive berberine derivatives. Bioorg Med Chem Lett (2006) 0.96
Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. J Control Release (2010) 0.96
Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study. Mov Disord (2009) 0.94
The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience. Br J Haematol (2005) 0.94
Chitosan micro- and nanospheres: fabrication and applications for drug and DNA delivery. Mini Rev Med Chem (2009) 0.93
Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study. Eur Neuropsychopharmacol (2009) 0.92
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties. J Mol Med (Berl) (2008) 0.92
Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20. Colloids Surf B Biointerfaces (2010) 0.91
Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly. Br J Haematol (2008) 0.91
HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells. Int J Cancer (2009) 0.91
Solid lipid nanoparticles incorporated in dextran hydrogels: a new drug delivery system for oral formulations. Int J Pharm (2006) 0.91
Interhemispheric transfer of phosphenes generated by occipital versus parietal transcranial magnetic stimulation. Exp Brain Res (2008) 0.90
Structural stability and increase in size rationalize the efficiency of lipoplexes in serum. Langmuir (2009) 0.90
Oral-facial-digital syndrome type VI: is C5orf42 really the major gene? Hum Genet (2014) 0.90
Protein flexibility in virtual screening: the BACE-1 case study. J Chem Inf Model (2012) 0.90
Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells. Colloids Surf B Biointerfaces (2013) 0.90
Polyethylenimine and chitosan carriers for the delivery of RNA interference effectors. Expert Opin Drug Deliv (2013) 0.90
Prevalence of bifid median nerve at wrist assessed through ultrasound. Neurol Sci (2011) 0.89
MDM4 enhances p53 stability by promoting an active conformation of the protein upon DNA damage. Cell Cycle (2012) 0.89
Analysis and modeling of swelling and erosion behavior for pure HPMC tablet. J Control Release (2007) 0.89
B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation. Transplantation (2008) 0.89
Mitochondrial MDM4 (MDMX): an unpredicted role in the p53-mediated intrinsic apoptotic pathway. Cell Cycle (2009) 0.88
Xanthene and xanthone derivatives as G-quadruplex stabilizing ligands. Molecules (2013) 0.88
Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds. Bioorg Med Chem Lett (2007) 0.88
Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates. Chem Biol Interact (2010) 0.88
Dopamine agonists and sleepiness in PD: review of the literature and personal findings. Sleep Med (2004) 0.87
Maternal thyroid hormones are transcriptionally active during embryo-foetal development: results from a novel transgenic mouse model. J Cell Mol Med (2010) 0.87
Application of microfluidic technology to the BIOMED-2 protocol for detection of B-cell clonality. J Mol Diagn (2011) 0.86
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes. Nephrol Dial Transplant (2014) 0.85
Reproductive life milestones in women with Parkinson's disease. Funct Neurol (2004) 0.85
Perylene diimides with different side chains are selective in inducing different G-quadruplex DNA structures and in inhibiting telomerase. Bioorg Med Chem Lett (2002) 0.85
Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS). J Thromb Thrombolysis (2009) 0.85
N-cyclic bay-substituted perylene G-quadruplex ligands have selective antiproliferative effects on cancer cells and induce telomere damage. J Med Chem (2011) 0.84
IGF-1R/MDM2 relationship confers enhanced sensitivity to RITA in Ewing sarcoma cells. Mol Cancer Ther (2012) 0.84
Factors determining the superior performance of lipid/DNA/protammine nanoparticles over lipoplexes. J Med Chem (2011) 0.84
Non-phospholipid vesicles for pulmonary glucocorticoid delivery. Eur J Pharm Biopharm (2005) 0.83
Regulation of the microsomal prostaglandin E synthase-1 in polarized mononuclear phagocytes and its constitutive expression in neutrophils. J Leukoc Biol (2007) 0.83
Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes. Br J Haematol (2011) 0.83
L-dopa- and dopamine-(R)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties. J Med Chem (2006) 0.82
The role of cytoskeleton networks on lipid-mediated delivery of DNA. Ther Deliv (2013) 0.82
Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases. J Med Chem (2012) 0.82
Rotigotine transdermal patch in the management of Parkinson's disease (PD) and its night-time use for PD-related sleep disorders. Funct Neurol (2010) 0.82
Extramedullary blast crisis occurring in a Philadelphia-positive chronic myeloid leukemia patient with major cytogenetic response to imatinib. Haematologica (2004) 0.81
Polysorbate 20 vesicles as oral delivery system: in vitro characterization. Colloids Surf B Biointerfaces (2012) 0.81
Influence of the formulation components on the properties of the system SLN-dextran hydrogel for the modified release of drugs. J Microencapsul (2009) 0.80
Structural and rheological characterization of Scleroglucan/borax hydrogel for drug delivery. Int J Biol Macromol (2003) 0.80
Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma. Cancer Gene Ther (2005) 0.80
A novel method to obtain chitosan/DNA nanospheres and a study of their release properties. Nanotechnology (2008) 0.80
Endogenous serum erythropoietin and no-reflow in patients with ST-elevation myocardial infarction. Eur J Clin Invest (2011) 0.80
Liposomal chemotherapeutics. Future Oncol (2013) 0.80
Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates. ChemMedChem (2010) 0.80
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer. J Med Chem (2008) 0.80
Selective interactions of perylene derivatives having different side chains with inter- and intramolecular G-quadruplex DNA structures. A correlation with telomerase inhibition. Bioorg Med Chem Lett (2005) 0.79
Modified micellar electrokinetic chromatography in the analysis of catechins and xanthines in chocolate. Electrophoresis (2004) 0.79
The structure of the Ce(III)-angiotensin II complex as obtained from NMR data and molecular dynamics calculations. J Inorg Biochem (2003) 0.79